Skip to search formSkip to main contentSkip to account menu

Pancreatic Endocrine Carcinoma

Known as: Islet cell carcinoma, Malignant Pancreatic Endocrine Tumor, High Grade Pancreatic Neuroendocrine Carcinoma 
An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the pancreas. The mitotic count is… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1999
Review
1999
Apoptosis, the process of programmed cell death, plays a critical role in many normal and pathological (disease) processes. 1 In… 
1992
1992
PURPOSE A phase II trial that used fluorouracil (5-FU) and chlorozotocin (CTZ) was performed in patients with metastatic islet… 
Highly Cited
1991
Highly Cited
1991
Mutations within codon 12 leading to activation of Kirsten-ras (K-ras) genes occur in a wide variety of human tumors, but have… 
Highly Cited
1990
Highly Cited
1990
In 98 patients with histologically proved pancreatic islet cell carcinoma who were studied between 1950 and 1987, 55 had… 
Review
1987
Review
1987
Malignant intra-abdominal neuroendocrine tumors are rare; consequently, a standard chemotherapeutic protocol for patients with… 
1978
1978
The immunologic specificity of human prostatic acidphosphatase has been established by several previous investigations as well as… 
Highly Cited
1977
Highly Cited
1977
Described here is a patient who had an islet cell carcinoma containing both glucagon (glucagonoma) and insulin (insulinoma… 
1969
1969
Streptozotocin, a new antitumor agent with diabetogenie properties, was administered to a patient with functioning islet cell…